The Diagnosis and Treatment of Optic Neuritis

Helmut Wilhelm1, Martin Schabet

  • 1University Eye Hospital, University Hospital Tübingen, Department of Neurology, Klinikum Ludwigsburg.

Abstract

Insights

Optic neuritis, often the first sign of multiple sclerosis (MS), typically presents with eye pain and vision loss. Early MRI can predict MS risk, and treatment may involve steroids or immune prophylaxis.

Area of Science:

  • Neurology
  • Ophthalmology

Background:

  • Optic neuritis frequently serves as the initial clinical presentation of multiple sclerosis (MS).
  • The incidence of optic neuritis in Central Europe is approximately 5 cases per 100,000 individuals annually.

Purpose of the Study:

  • To review the diagnosis, clinical course, and management of optic neuritis.
  • To discuss the association between optic neuritis and multiple sclerosis (MS).

Main Methods:

  • Literature review utilizing PubMed database searches.
  • Analysis of relevant clinical guidelines.
  • Incorporation of authors' clinical expertise.

Main Results:

  • Diagnosis relies on symptoms like eye pain on movement and subacute vision loss, with characteristic pupillary light reflex abnormalities.
  • Most cases (95%) resolve, but atypical presentations may indicate neuromyelitis optica or neuroretinitis.
  • Intravenous methylprednisolone accelerates recovery but doesn't alter the final visual outcome; brain MRI can assess future multiple sclerosis risk.

Conclusions:

  • Optic neuritis is generally distinguishable from other optic nerve disorders, though atypical forms necessitate specific treatments.
  • For individuals at high risk of developing multiple sclerosis, prophylactic treatment with beta-interferon or glatiramer acetate is advised.

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K